Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
about
Trials with 'epigenetic' drugs: an updateA Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective InhibitorsSmall-molecular modulators of cancer-associated epigenetic mechanisms.Computational exploration of zinc binding groups for HDAC inhibitionHistone deacetylase inhibitors in clinical studies as templates for new anticancer agents.Search for the pharmacophore of histone deacetylase inhibitors using pharmacophore query and docking studyQuantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries.Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro.Butyrate histone deacetylase inhibitors.Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with Indole-Containing Cap GroupSirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).Antioxidant, lipoxygenase and histone deacetylase inhibitory activities of Acridocarbus orientalis from Al Ain and Oman.PXD101 analogs with L-phenylglycine-containing branched cap as histone deacetylase inhibitors.Biological Activity of Spirocyclic Hydroxamic Acids.The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
P2860
Q27000542-47A1FC45-E615-415C-9AA2-324DAFA2D62DQ28830529-B8849F4E-8F3B-46CD-AAE0-ACF5EF6394E0Q34628002-1ACB7D2F-E3FC-4672-B8DC-A1726582AF84Q34668407-DA1C2746-A5C8-40A2-8E2E-4260E9D95359Q35214924-C2593F7A-E414-41A1-B90C-E3661A2C5053Q35542579-20162AD2-98B0-4276-A5F6-8F410EE70C52Q36319273-3CCFAE20-AE41-4DC2-A3AE-F1A55D343527Q36482722-1571589C-0D3B-433A-8168-89173E6C9028Q36574546-D48B5A7B-C77E-456A-AB6A-A4296BAB2EDDQ36671179-D8F3084A-B97E-4F12-AC64-AF2A9B599822Q37710177-1382FC87-7BB6-4A73-BF77-9B39463F5A0AQ38631566-B543B53B-EF5C-4F88-8DA6-B4D8E269BB11Q47819887-6BA0B420-386A-4FFB-B6F7-63B5E91E5DC6Q48219950-9BF7D836-E6BC-4DC2-82AF-CCCD7C6DD745Q48410905-2BE891C9-1848-418C-B617-C19BE3DBB90FQ53561135-6AF4DE6A-1B1B-442D-A3BD-F9F8BECB3AE7
P2860
Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histone deacetylase inhibitors ...... ory and new QSAR perspectives.
@en
type
label
Histone deacetylase inhibitors ...... ory and new QSAR perspectives.
@en
prefLabel
Histone deacetylase inhibitors ...... ory and new QSAR perspectives.
@en
P2860
P356
P1476
Histone deacetylase inhibitors ...... ory and new QSAR perspectives.
@en
P2093
Dimitra Hadjipavlou-Litina
Eleni Pontiki
P2860
P356
10.1002/MED.20200
P577
2010-02-16T00:00:00Z